UK markets open in 2 hours 56 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
17.49-0.22 (-1.24%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
85,767
83,138
69,888
24,181
0
Cost of revenue
25,941
25,333
4,833
641
-
Gross profit
59,826
57,805
65,055
23,540
-
Operating expenses
Research development
72,725
74,007
91,378
86,123
72,078
Selling general and administrative
132,880
137,184
138,402
120,614
73,615
Total operating expenses
205,795
213,495
252,547
233,282
145,693
Operating income or loss
-145,969
-155,690
-187,492
-209,742
-145,693
Interest expense
27,002
26,476
15,255
2,531
2,368
Total other income/expenses net
1,405
2,326
106
-23,722
-555
Income before tax
-170,627
-177,856
-199,671
-232,566
-146,863
Income tax expense
5,309
5,245
-90
3
-1,758
Income from continuing operations
-175,936
-183,101
-199,581
-232,569
-145,105
Net income
-175,936
-183,101
-199,581
-232,569
-145,105
Net income available to common shareholders
-175,936
-183,101
-199,581
-232,569
-145,105
Basic EPS
-
-3.99
-4.39
-5.58
-4.11
Diluted EPS
-
-3.99
-4.39
-5.58
-4.11
Basic average shares
-
45,897
45,427
41,664
35,324
Diluted average shares
-
45,897
45,427
41,664
35,324
EBITDA
-
-117,222
-166,302
-227,593
-143,085